Skip to main content
. 2023 Dec 13;10(1):e23629. doi: 10.1016/j.heliyon.2023.e23629

Table 2.

Demographic and clinic characteristics according the survival or not survival in pediatric patients with COVID-19.

Survival n = 103,454 Non-survival n = 669 p-value
Sex 0.019
Female 51,865 (50.1) 305 (45.5)
Male 51,599 (49.8) 365 (54.4)
Age, years 14 (9–17) 4 (0–15) <0.001
Age
<1 3203 (3.1) 186 (27.8)
1-4 8213 (7.9) 150 (22.4) <0.001
5-9 14,523 (14.0) 68 (10.1)
10-14 29,527 (28.5) 97 (14.5)
15-18 47,998 (46.3) 168 (25.1)
Pneumonia 2615 (2.5) 443 (66.2) <0.001
Comorbidities
Diabetes 601 (0.5) 42 (6.3) <0.001
Hypertension 510 (0.4) 43 (6.4) <0.001
Obesity 3858 (3.7) 52 (7.7) <0.001
Asthma 3054 (2.9) 11 (1.6) 0.047
Immunosuppression 762 (0.7) 64 (9.6) <0.001
HIV/AIDS 109 (0.1) 3 (0.4) 0.007
Cardiac disease 536 (0.5) 37 (5.5) <0.001
Kidney disease 281 (0.2) 42 (6.3) <0.001
Symptoms
Fever 47,644 (46.1) 507 (75.9) <0.001
Cough 54,050 (52.2) 379 (56.7) 0.022
Odynophagia 34,198 (33.1) 160 (24.5) <0.001
Dyspnea 9978 (9.6) 484 (72.3) <0.001
Diarrhea 12,204 (11.8) 112 (16.8) <0.001
Thoracic pain 10,147 (9.8) 125 (19.3) <0.001
Headache 54,482 (52.7) 270 (41.4) <0.001
Myalgia 29,379 (28.4) 185 (28.4) 0.971
Arthralgia 23,766 (23.0) 172 (26.5) 0.035
General condition attack 14,092 (21.6) 204 (60.7) <0.001
Rhinorrhea 31,984 (30.9) 120 (18.0) <0.001
Polypnea 4077 (3.9) 243 (36.4) <0.001
Vomit 5779 (5.6) 102 (15.3) <0.001
Conjunctivitis 8037 (7.8) 37 (5.5) 0.029
Cyanosis 1637 (1.5) 127 (19.0) <0.001
Anosmia 14,590 (15.1) 24 (4.6) <0.001
Dysgeusia 13,006 (13.5) 20 (3.9) <0.001
Irritability 14,780 (14.3) 292 (43.9) <0.001
Calophrios 19,663 (19.0) 148 (22.6) 0.021

Chi-square test was performed for categorical variables and Student t-test or Mann-Whitney U test for continuous variables. Qualitative variables are presented in n (%).